Genetic Variation on 9p22 Is Associated with Abnormal Ovarian Ultrasound Results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

• Nicolas Wentzensen ,

  * E-mail: wentzenn@mail.nih.gov

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Amanda Black,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Kevin Jacobs,

  Affiliation Core Genotyping Facility, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Hannah P. Yang,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Christine D. Berg,

  Affiliation Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Neil Caporaso,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Ulrike Peters,

  Affiliation Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Lawrence Ragard,

  Affiliation Westat, Rockville, Maryland, United States of America

  ⨯
• Saundra S. Buys,

  Affiliation Oncology Division, Huntsman Cancer Institute, Salt Lake City, Utah, United States of America

  ⨯
• Stephen Chanock,

  Affiliations Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America, Core Genotyping Facility, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Patricia Hartge

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯